<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="30068">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01850017</url>
  </required_header>
  <id_info>
    <org_study_id>16150</org_study_id>
    <nct_id>NCT01850017</nct_id>
  </id_info>
  <brief_title>Study of Dexmedetomidine in Spine Surgery</brief_title>
  <official_title>Prospective Randomized Double Blind Study of Intraoperative Dexmedetomidine and Postoperative Pain Control in Patients Undergoing Multi-level Thoraco-lumbar Spine Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Virginia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Virginia</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will conduct a prospective randomized double blind study comparing
      methadone plus methadone and intraoperative dexmedetomidine in multi-level spine surgery in
      two randomized groups. The investigators plan to document the intraoperative opioid
      requirements, time to first dose of opioids postoperatively and total opioid consumption in
      the first 24, 48 and 72 hours. The incidence of intra and postoperative complications will
      be assessed.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients presenting for thoracic and/or lumbar spine surgery with neuromonitoring
      (MEP/SSEP/EMG)will be recruited. Standard anesthesia monitoring will be performed.
      Randomized to a placebo or dexmedetomidine arm. Both groups will receive methadone 0.2 mg/kg
      ideal weight after induction of anesthesia.

      The placebo/dexmedetomidine will be loaded at 1 mcg/kg over 20 minutes and then a continuous
      infusion of 0.5 mcg/kg/h for the duration of the procedure.

      Intraoperative analgesia will be provided with fentanyl and dilaudid per the anesthesia
      team.

      Upon closure the study drug will be terminated. Patients will be followed up for 72 hours
      after surgery. Total opiate consumption and visual analogue scale ratings will be
      documented.

      Intra and postoperative inotrope/pressor requirements will be recorded.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2012</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Opiate consumption</measure>
    <time_frame>72 hours post surgery</time_frame>
    <safety_issue>No</safety_issue>
    <description>We will measure total opiate consumption 72 hours post surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain Scores on the Visual Analog Scale</measure>
    <time_frame>72 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>We will measure pain scores on the Visual analogue scale after surgery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Collapse of Thoracic Vertebra</condition>
  <condition>Collapse of Lumbar Vertebrae</condition>
  <arm_group>
    <arm_group_label>Methadone and dexmedetomidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Standard American Society of Anesthesiology monitors. Midazolam 1-2 mg for pre-operative sedation. Lidocaine 0.5-1 mg/kg with induction. Propofol 1-2 mg/kg with induction. Fentanyl 0.5-1 mcg/kg with induction. Rocuronium 0.5 -1 mg/kg with induction. Total intravenous anesthesia with propofol for maintainence of anesthesia. Titrated to maintain BIS (bispectral index) between 30-60.
Methadone 0.2 mg/kg ideal body weight and dexmedetomidine 1 mcg/kg load over 20 minutes followed by a continuous infusion of 0.5 mcg/kg/h for the duration of the procedure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Methadone and placebo</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard American Society of Anesthesiology monitors. Midazolam 1-2 mg for pre-operative sedation. Lidocaine 0.5-1 mg/kg with induction. Propofol 1-2 mg/kg with induction. Fentanyl 0.5-1 mcg/kg with induction. Rocuronium 0.5 -1 mg/kg with induction. Total intravenous anesthesia with propofol for maintainence of anesthesia. Titrated to maintain BIS (bispectral index) between 30-60.
Methadone 0.2 mg/kg ideal body weight and placebo (normal saline) 1 mcg/kg load over 20 minutes followed by a continuous infusion of 0.5 mcg/kg/h for the duration of the procedure</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>In the intervention arm dexmedetomidine at a dose of  1 mcg/kg over 20 mins followed by an infusion of 0.5 mcg/kg/h for the duration of the surgery.</description>
    <arm_group_label>Methadone and dexmedetomidine</arm_group_label>
    <other_name>Precedex</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18-80 years of age

          -  Elective multi-level thoracic and/or lumbar spine surgery requiring SSEP, EMG or MEP
             monitoring

        Exclusion Criteria:

          -  Emergency spine surgery

          -  Age &lt; 18 years

          -  Pregnant patients

          -  Advanced heart block: Mobitz type II block or atrio-ventricular dissociation in a
             previous EKG.

          -  Any individual with stage 4 or greater chronic kidney disease (eGFR&lt; 30 ml/min)
             and/or requiring dialysis or liver failure defined as a history of cirrhosis or
             fulminant hepatic failure

          -  Any individuals on preoperative methadone therapy

          -  Preoperative dexmedetomidine use

          -  Preoperative systolic hypertension defined by a systolic blood pressure greater than
             150 mmHg in the surgical admission suite

          -  Enrolled in another study within 30 days
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bhiken Naik, MBBCh</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Virginia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ali Kazemi, MD</last_name>
    <phone>571-264-1119</phone>
    <email>ak2ja@virginia.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Virginia</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ali Kazemi, MD</last_name>
      <phone>571-264-1119</phone>
      <email>ak2ja@virginia.edu</email>
    </contact>
    <contact_backup>
      <last_name>Bhiken Naik, MBBCh</last_name>
      <phone>434-924-2283</phone>
      <email>bin4n@virginia.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Bhiken Naik, MBBCh</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Gottschalk A, Durieux ME, Nemergut EC. Intraoperative methadone improves postoperative pain control in patients undergoing complex spine surgery. Anesth Analg. 2011 Jan;112(1):218-23. doi: 10.1213/ANE.0b013e3181d8a095. Epub 2010 Apr 24.</citation>
    <PMID>20418538</PMID>
  </reference>
  <reference>
    <citation>Korkmaz Dilmen O, Tunali Y, Cakmakkaya OS, Yentur E, Tutuncu AC, Tureci E, Bahar M. Efficacy of intravenous paracetamol, metamizol and lornoxicam on postoperative pain and morphine consumption after lumbar disc surgery. Eur J Anaesthesiol. 2010 May;27(5):428-32. doi: 10.1097/EJA.0b013e32833731a4.</citation>
    <PMID>20173643</PMID>
  </reference>
  <reference>
    <citation>Khan ZH, Rahimi M, Makarem J, Khan RH. Optimal dose of pre-incision/post-incision gabapentin for pain relief following lumbar laminectomy: a randomized study. Acta Anaesthesiol Scand. 2011 Mar;55(3):306-12. doi: 10.1111/j.1399-6576.2010.02377.x.</citation>
    <PMID>21288211</PMID>
  </reference>
  <reference>
    <citation>Loftus RW, Yeager MP, Clark JA, Brown JR, Abdu WA, Sengupta DK, Beach ML. Intraoperative ketamine reduces perioperative opiate consumption in opiate-dependent patients with chronic back pain undergoing back surgery. Anesthesiology. 2010 Sep;113(3):639-46. doi: 10.1097/ALN.0b013e3181e90914.</citation>
    <PMID>20693876</PMID>
  </reference>
  <reference>
    <citation>Grewal A. Dexmedetomidine: New avenues. J Anaesthesiol Clin Pharmacol. 2011 Jul;27(3):297-302. doi: 10.4103/0970-9185.83670.</citation>
    <PMID>21897496</PMID>
  </reference>
  <reference>
    <citation>Chan AK, Cheung CW, Chong YK. Alpha-2 agonists in acute pain management. Expert Opin Pharmacother. 2010 Dec;11(17):2849-68. doi: 10.1517/14656566.2010.511613. Epub 2010 Aug 13. Review.</citation>
    <PMID>20707597</PMID>
  </reference>
  <reference>
    <citation>McQueen-Shadfar LA, Megalla SA, White WD, Olufolabi AJ, Jones CA, Habib AS. Impact of intraoperative dexmedetomidine on postoperative analgesia following gynecologic surgery. Curr Med Res Opin. 2011 Nov;27(11):2091-7. doi: 10.1185/03007995.2011.618491. Epub 2011 Sep 14.</citation>
    <PMID>21916531</PMID>
  </reference>
  <reference>
    <citation>Turgut N, Turkmen A, Gökkaya S, Altan A, Hatiboglu MA. Dexmedetomidine-based versus fentanyl-based total intravenous anesthesia for lumbar laminectomy. Minerva Anestesiol. 2008 Sep;74(9):469-74.</citation>
    <PMID>18762754</PMID>
  </reference>
  <verification_date>May 2013</verification_date>
  <lastchanged_date>May 6, 2013</lastchanged_date>
  <firstreceived_date>April 30, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Opiate consumption</keyword>
  <keyword>Visual Analogue Scale</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Shock</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Methadone</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
